A4
Showing 9926 - 9950 of >10,000
Chronic Myelomonocytic Leukemia, de Novo MDS, MDS Trial in Buffalo, London, Toronto (sunitinib malate)
Completed
- Chronic Myelomonocytic Leukemia
- +3 more
- sunitinib malate
-
Buffalo, New York
- +3 more
Jul 27, 2018
Mental Health Wellness 1 Trial in Stirling (Sprint interval training (SIT), Reduced-exertion high-intensity interval training
Not yet recruiting
- Mental Health Wellness 1
- Sprint interval training (SIT)
- +2 more
-
Stirling, Midlothian, United KingdomUniversity of Stirling
Oct 4, 2023
Traumatic Brain Injury Trial (Sildenafil Citrate low dose, Placebo, Sildenafil medium dose)
Not yet recruiting
- Traumatic Brain Injury
- Sildenafil Citrate low dose
- +3 more
- (no location specified)
Mar 21, 2023
Cancer Trial in Salt Lake City (CHAT-S, Usual Care)
Not yet recruiting
- Cancer
- CHAT-S
- Usual Care
-
Salt Lake City, UtahUniversity of Utah
Apr 12, 2023
Healthy Trial in Greifswald (Thiamin)
Not yet recruiting
- Healthy
- Thiamin
-
Greifswald, Mecklenburg-Vorpommern, GermanyUniversity Medicine Greifswald, Institute of Pharmacology
Nov 7, 2023
Meningitis Trial in Oxford (4CMenB)
Completed
- Meningitis
- 4CMenB
-
Oxford, United KingdomOxford Vaccine Group, Centre for Clininal Vaccinology & Tropical
Oct 17, 2018
Trauma-Sensitive Mindfulness and Compassion Intervention
Completed
- Complex Post-Traumatic Stress Disorder
- TMC Treatment Approach
-
Vikersund, NorwayModum Bad
Aug 16, 2023
Substance Use, Parenting, Communication Trial in Durham (Media Ready Parent, Active Control Program)
Recruiting
- Substance Use
- +2 more
- Media Ready Parent
- Active Control Program
-
Durham, North Carolinainnovation Research and Training
Jun 9, 2023
Heart Failure, Caregiver Burden Trial (TPA4You, Attention control group)
Not yet recruiting
- Heart Failure
- Caregiver Burden
- TPA4You
- Attention control group
- (no location specified)
May 15, 2023
Non-erosive Reflux Disease(NERD) Trial in Korea, Republic of (EsoDuo Tab. 20/800mg)
Completed
- Non-erosive Reflux Disease(NERD)
- EsoDuo Tab. 20/800mg
-
Busan, Korea, Republic of
- +37 more
Dec 23, 2019
Cirrhosis, Hepatocellular Carcinoma Trial in Pittsburgh (OASIS DA training, Current DA Tool training)
Not yet recruiting
- Cirrhosis
- Hepatocellular Carcinoma
- OASIS DA training
- Current DA Tool training
-
Pittsburgh, PennsylvaniaVA Pittsburgh Healthcare System University Drive Division, Pitts
Sep 27, 2023
Pre-hypertension, Cardiovascular Diseases Trial in Chicago (Watermelon Flesh Dose 1, Watermelon Flesh Dose 2, Control)
Recruiting
- Pre-hypertension
- Cardiovascular Diseases
- Watermelon Flesh Dose 1
- +2 more
-
Chicago, IllinoisClinical Nutrition Research Center
May 26, 2023
Respiratory Distress of Newborn Trial in Minneapolis, Madison (Ultrasound)
Not yet recruiting
- Respiratory Distress of Newborn
- Ultrasound
-
Minneapolis, Minnesota
- +1 more
Nov 14, 2023
ADHD Trial (FRx-001, FRx-003, FRx-004)
Not yet recruiting
- ADHD
- FRx-001
- +2 more
- (no location specified)
Jan 26, 2023
Respiratory Syncytial Viruses Trial in Worldwide (Lumicitabine, Placebo)
Terminated
- Respiratory Syncytial Viruses
- Lumicitabine
- Placebo
-
Long Beach, California
- +28 more
Dec 13, 2019
CHF, Type II Diabetes Trial in Worldwide (vildagliptin, of vildagliptin)
Completed
- Congestive Heart Failure
- Type II Diabetes Mellitus
- vildagliptin
- placebo of vildagliptin
-
Benesov, Czech Republic, Czechia
- +93 more
Dec 11, 2020
Drug Resistant Partial Onset Seizure Trial in Worldwide (ganaxolone, Placebo)
Completed
- Drug Resistant Partial Onset Seizure
- ganaxolone
- Placebo
-
Birmingham, Alabama
- +70 more
Aug 19, 2020
Symptomatic Irreversible Pulpitis Trial in Cairo (mepivicane HCl, articane HCl)
Unknown status
- Symptomatic Irreversible Pulpitis
- mepivicane hydrochloride
- articane hydrochloride
-
Cairo, EgyptFaculty of Dentistry
Oct 31, 2018
Premenstrual Syndrome Trial in Santa Monica (Funk It Cycle Bites)
Recruiting
- Premenstrual Syndrome
- Funk It Cycle Bites
-
Santa Monica, CaliforniaCitruslabs
Jun 2, 2023
Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)
Recruiting
- Metabolic Associated Fatty Liver Disease
- LUDLEV®300 mg/46.2 mg
- Placebo
-
Mexico, Veracruz, MexicoAna Delfina Cano Contreras
Jun 12, 2023
Symptomatic Superficial Vein Thrombosis Trial in Canada (Rivaroxaban, Placebo)
Completed
- Symptomatic Superficial Vein Thrombosis
- Rivaroxaban
- Placebo
-
Edmonton, Alberta, Canada
- +10 more
Dec 3, 2018